Fasikl key facts
- Developer of wearable neuro-AI therapeutic devices designed for alleviating tremor-related functional limitations.
- It has raised $59.9M; the latest was Later Stage VC ($26.6M) in Sep 2025.
- Notable investors include Google for Startups, Qiming Venture Partners, iSeed Ventures, Llama Venture, Google Accelerator — 8 tracked in total.
- Status: Privately Held (backing).
- ·Watch Fasikl: the Monday email on marks, rounds and moves
Fasikl funding rounds
No funding rounds for Fasikl are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Fasikl investors
8 investors are on record for Fasikl, including Google for Startups, Qiming Venture Partners, iSeed Ventures and Llama Venture.
About Fasikl
Developer of wearable neuro-AI therapeutic devices designed for alleviating tremor-related functional limitations. The company's device integrates artificial intelligence with bioelectronic medicine that continuously monitors and modulates neural activity through cloud-connected adaptive stimulation, enabling patients to adjust therapy in real time and use it independently or alongside medication.
- Sector
- Healthcare
- HQ
- Bloomington, MN, United States
- Founded
- 2019
- Employees
- 13
- Website
- fasikl.com/
- Ownership
- Privately Held (backing)
Is this your company? Profiles are maintained at PrivateMarketView, the data platform behind this page — sign in with your work email to keep it current, or tell us what's wrong.
Fasikl doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.